Clinical trial
Dexmedetomidine for Prevention of Postoperative Delirium in Patients After Intracranial Operation for Brain Tumor: a Multicenter Randomized Controlled Trial
NCT04399343 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dexmedetomidine for Prevention of Postoperative Delirium in Patients After Intracranial Operation for Brain Tumor: a Multicenter Randomized Controlled Trial
- Lead sponsor
- Capital Medical University
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- March 1, 2021
- Completion date
- October 1, 2021
- Enrollment
- 700 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.